A Review for Gastro - Retentive Drug Delivery System
Inadequate pharmacokinetic properties may be connected with the widespread use of oral dose forms in disease treatment. Because of the formulation's rapid transit through the gastrointestinal tract (GIT), it can be challenging to achieve therapeutic levels of the medicine in specific situations when it is barely soluble; In addition, some medications must work locally due to a gastric disease, although they only last a short period in the stomach. Numerous studies have been done to identify formulations that can enhance all of these characteristics while extending stomach residence time. Many orally delivered medications advantageous for from the extended stomach retention time provided by gastroretentive controlled drug delivery systems.With a focus on current methods for extending stomach residence duration, the study's objective was to examine, gather, and present the preceding and contemporary literatures in a shorter format. The current review briefly discusses the need for GRDDS., Pharmaceutical importance’s of GRDDS, Physiology of stomach, Stomach functionalities, Approaches of GRDDS, factors controlling gastric retention, advantages , disadvantages, Method of preparation of Gastro-retentive Multiparticulate system, Polymeric material in gastroretentive formulations, Evaluation of Gastroretentive dosage form, comparsion between Conventional and Gastroretentive drug delivery system.
2. Streubel A, Siepmann J, Bodmeier R; Gastroretentive Drug Delivery System; Expert Opin Drug Delivery; 2006; 3 (2): 217-233.
3. Kothari Abhaykumar H, Jaimini Manish, Gastroretentive drug delivery system and its approaches: a review, International journal of pharmaceutical research and development, 2013, 4(12), 7-18.
4. Singh BN and Kim. Floating drug delivery systems: an approach to controlled drug delivery via gastric retention. J. Control. Release.2000; 63: 235-239.
5. Ali J, Arora S, Khar RK. Floating drug delivery System: A Review. AAPS Pharm Sci Tech. 2005; 06(03): E372-E390.
6. Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery system. Expert Opin Drug Deliv 2006; 3(2): 217-233.
7. Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems.Trop. J Pharm Res 2008; 7(3): 1055-66.
8. S.J. Hwang, H Park and K Park, “Gastric Retentive Drug Delivery Systems,” Critical Reviews in Therapeutic Drug Carrier Systems, 15 (3) (1998), pp. 243-284.
9. Swetha S, Allena RT and Gowda DV: A comprehensive review on gastroretentive drug delivery systems. International Journal of Pharmaceutical and Biomedical Research 2012; 3:1285-1293.
10. Kawatra M, Jain U and Ramana J: Recent advances in floating microspheres as gastro-retentive drug delivery system: A review. International Journal of Recent Advances in Pharmaceutical Research 2012; 2:5-23.
11. More, S., Gavali, K., Doke, O., Kasgawade, P. (2018). Gastroretentive drug delivery system. Journal of Drug Delivery and Therapeutics, 8 (4), 24–35. doi: http://doi.org/10.22270/jddt.v8i4.1788
12. Klausner EA, Lavy E, Friedman M, et al. Expandable gastroretentive dosage forms. J Control Release 2003;90:143– 162.
13. Laulicht B, Tripathi A, Schlageter V, et al. Understanding gastric forces calculated from high-resolution pill tracking. ProcNatlAcadSci U S A 2010;107:8201–8206.
14. Talukder R, Fassihi R. Gastroretentive delivery systems: a mini review. Drug DevInd Pharm 2004;30:1019–1028.
15. Gutierrez-Rocca J, Omidian H, Shah K. Progresses in gastroretentive drug delivery systems. Bus Brief Pharmatech 2003;15:3–6.
16. Anne Waugh and Allison Grant. The digestive system: Stomach-Functions of stomach. Ross ans Wilson anatomy and physiology in health and illness.Edited by Elsiver Publications. 2014; 12th Edition: 301.
17. Clarke GM, Newton JM and Short MD. Gastrointestinal transit of pellets of differing size and density.International journal pharmaceutics. 1993;100(13):81-92.
18. Moes AJ. Gastric retention system for oral drug delivery.Business briefing.Pharmatech. 2003;157-159.
19. Prajapati VD, Jani GK, Khutliwala TA, Zala BS. Raft forming systeman upcoming approach of gastroretentive drug delivery system. J Control Release 2013;168:151-65.
20. Abouelatta SM, Aboelwafa AA, El-Gazayerly ON. Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug. Drug Deliv 2018;25:1161-74.
21. Hampson FC, Jolliffe IG, Bakhtyari A, Taylor G, Sykes J, Johnstone LM, et al. Alginate-antacid combinations: Raft formation and gastric retention studies. Drug DevInd Pharm 2010;36:614-23.
22. Abou Youssef NA, Kassem AA, El-Massik MA, Boraie NA.Development of gastroretentive metronidazole floating raft system for targeting Helicobacter pylori.Int J Pharm 2015;486:297-305.
23. Garg S, Sharma S. Gastroretentive Drug Delivery System. Business Briefing: Pharmatech.2003; 160-166.
24. Misra SK. Gastrointestinal targetting drug delivery system: A Review. Journal of Pharmacy Research. 2011;4(8):2751- 2754.
25. Rao BP, Kottan NA, Snehith VH and Ramesh C. Development of gastroretentive drug delivery system of Cephalexin by using factorial design. ARE Pharmaceutical. 2009;50: 8.
26. Sheth PR and Tossounian J. The hydrodyanamically balanced system. A novel drug delivery system for oral use.Drug delivery Indian Pharmaceutics. 2010;3(1):819-833.
27. Sharma N, Agarwal D, Gupta M and Khinchi M: A comprehensive review on floating drug delivery system. International Journal of Research in Pharmaceutical and Biomedical sciences 2011; 2:428-441.
28. Vasa S and Banji D: Approaches for gastrotentive drug delivery systems. International Journal of Applied Biology and Pharmaceutical Technology 2010; 1:589-601
29. Bhardwaj L, Sharma PK and Malviya R: A short review on gastro retentive formulations for stomach specific drug delivery: special emphasis on floating in-situ gel systems. African Journal of Basic and Applied Sciences 2011; 3:300-312.
30. Klausner, E. A., Lavy E., Friedman, M., Hoffman, A., (2003) Expandable gastroretentive dosage forms. J. Control. Release 90, 143–162.
31. Garg R., Gupta G.D. (2008) Progress in Controlled Gastroretentive Delivery Systems. Trop. J. Pharm. Res., 7 (3): 1055-1066
32. Hoffman A. (1998) Pharmacodynamic aspects of sustained release preparation. Adv. Drug Deliv.Rev. 33: 185-199.
33. Hoffman A., Stepensky D. (1999) Pharmacodynamic aspects of modes of drug administration for optimization of drug therapy. Crit. Rev. Ther. Drug carrier Syst. 16: 571-639.
A. Badoni , A. Ojha, G. Gnanarajani, P. Kothiyali; Review on Gastro Retentive Drug Delivery System; The Pharma Innovation, 2012;1(8): 32-42.
34. Streubel A, Siepmann J, Bodmeier R, Floating Microparticles Based on Low Density Foam Powder, Int. J. Pharm, 2002, 241, 279-N 292.
35. Kale R, Rao BS, Sharm S, Ramanmurthy KV, Preparation and Evaluation of Floatable Drug Delivery System of Ketorolac Tromethamine, Int. J. Pharm, 2001, 64- 65.
36. Muthuamy K, Govindarajan G, Ravi TK, Preparation and Evaluation of Lansoprazole Floating Micropellets, Indian J. Pharm. Sci, 2005, 67(1), 75-79.
37. Streubel A, Siepmann J, Bodmeier R, Floating Microparticles Based on Low Density Foam Powder, Int. J. Pharm, 2002, 241, 279- 292.
38. Streubel A, Siepmann J, Bodmeier R. Floating Matrix Tablets Based on Low Density Foam Powder, Effects of Formulation and Processing Parameters on Drug Release, Eur. J. Pharm. Sci, 2003, 18, 37-45.
39. Gaba P, Gaba M, Garg R and Gupta GD, Floating Microspheres, A Review. Pharmainfo.Net, 2008, 6(5), 121 123.
40. Streubel A, Siepmann J, Bodmeier R, Floating Microparticles Based on Low Density Foam Powder, Int. J. Pharm, 2002, 241, 279- 292.
41. Streubel A, Siepmann J, Bodmeier R. Floating Matrix Tablets Based on Low Density Foam Powder, Effects of Formulation and Processing Parameters on Drug Release, Eur. J. Pharm. Sci, 2003, 18, 37-45.
42. Singh BN, Kim KH, Floating Drug Delivery Systems: An Approach to Oral Controlled Drug Delivery Via Gastric Retention, J. Control. Rel, 2000, 63, 235-259.
43. Heng WS, Wong TW, Melt Processes for Oral Solid Dosage Forms, Pharm Tech, 2003, 1-6.
44. Chokshi R, Zia H, Hot Melt Extrusion Technique, A Review, Iranian J Pharm Res, 2004, 3: 3-16.
45. Breitenbach J., Melt Extrusion: From Process to Drug Delivery Technology, Eur J Pharm Biopharm, 2002, 54: 107 – 117.
46. Kidokoro M, Sasaki K, Haramiishi Y, Matahira N, Effect of Crystallization Behaviour of Polyethylene Glycol 6000 on the Properties of Granule Prepared by Fluidized Hot Melt Granulation (FHMG), Chem Pharm Bull, 2003, 51 (5): 487 – 493.
47. Parashar AK, Patel P, Gupta A, Jain N, Kurmi B. Synthesis Characterization and in vivo Evaluation of PEGylated PPI Dendrimer for Safe and Prolonged Delivery of Insulin. Drug Del Letters. 2019; 9: 248-63.
48. Ghori MU, Grover LM, Asare-Addo K, Smith AM, Conway BR. Evaluating the swelling, erosion, and compaction properties of cellulose ethers. Pharmaceutical Development and Technology. 2017; (2):183–97.
49. Zubedi SS, Mohammed S. Floating Tablets and its Polymers. Journal of Drug Delivery and Therapeutics. 2018; 8(5-s):16–24.
50. Sharma D, Sharma A. Gastroretentive drug delivery system - a mini review. Asian Pacific Journal of Health Sciences. 2014; (2):80–9.
51. Jafar M, Alghamdi HS, Khalid MS, Al-Hussain MJ, Alghamdi SA, Alahamad ZY, Almoumen AM. Enhanced analgesic activity and reduced gastric ulceration potential of ibuprofen sodium through a novel bouyant In Situ gelling system. Lat. Am. J. Pharm. 2019, 38:599–608.
52. Kim H, Lee CL, Lee S, et al. Mechanically robust gastroretentive drug-delivery systems capable of controlling dissolution behaviors of coground β lapachone. Pharmaceutics.2019, 11.
53. Hanif M, Abbas G. pH-responsive alginate-pectin polymeric rafts and their characterization. AdvPolym Technol. 2018; 37(5):1496– 506. Available from: http://dx.doi.org/10.1002/adv.21808.
54. R. Varges P, M. Costa C, S. Fonseca B, F. Naccache M, de Souza Mendes P. Rheological characterization of carbopol® dispersions in water and in water/glycerol solutions. Fluids [Internet]. 2019; 4(1):3. Available from: http://dx.doi.org/10.3390/fluids4010003.
55. Panda M, Rao MEB, Patra CN, Panda J, Panigrahi KC, Patro G. Formulation and development of floating multiple-unit minitablets of Nimodipine without using a gas-generating agent: in vitro and in vivo characterization. Futur J Pharm Sci. 2020; 6(1). Available from: http://dx.doi.org/10.1186/s43094-020-0021-x.
56. Lalge R, Thipsay P, Shankar VK, Maurya A, Pimparade M, Bandari S, et al. Preparation and evaluation of cefuroxime axetilgastroretentive floating drug delivery system via hot melt extrusion technology.Int J Pharm. 2019; 566:520–31. Available from: http://dx.doi.org/10.1016/j.ijpharm.2019.06.021.
57. Li Q, Guan X, Cui M, Zhu Z, Chen K, Wen H, et al. Preparation and investigation of novel gastro-floating tablets with 3D extrusionbased printing. Int J Pharm [Internet]. 2018; 535(1–2):325–32. Available from: http://dx.doi.org/10.1016/j.ijpharm.2017.10.037.
58. Panda S, Sailada NS, Devi B, Pattnaik S, Maharana L. Design of floating drug delivery systems: An update on polymeric advancements with special reference from natural origin. Int. J. Pharm. Sci. Rev. Res. 2016; 39:125–132.
59. Jose G R, Omidian H, Shah K. Progress In Gastroretentive Drug Delivery Systems, Pharm. Tech., 10th edition, 2003, 152-154.
60. Yen MK, Jenkins PG, Davis SS, Combs GA, Improvement of Delivery Capabilities of Microparticle Systems using Blend of Poly (D, L-Lactate Co-Glycoside) Poly (Ethylene Glycol), J ContRel, 1995, 37, 1-9.
61. Shimpi S, Chauhan B, Mahadik KR, Paradkar P, Preparation and Evaluation of Diltiazem Hydrochloride-Gelucire 43/01 Floating Granules Prepared by Melt Granulation, AAPS Pharmscitec, 2004, 5(3), Article 43.
62. Chen J, Blevins WE, Park H, Park K, Gastric Retention Properties of Superporous Hydrogel Composites, J Con Rel, 2000, 64, 39-51.
63. Deshpande A A, Rhodes C T, Shah N H. Controlled release drug delivery system for prolonged gastric residence: an overview,” Drug Dev. Ind. Pharm, 22(6), 1996, 531- 539.
64. Desai S, Bolton S. A floating controlled release drug delivery system: in vitro- in vivo evaluation, Pharm Res, 10(9), 1993, 1321-1325.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).